Tonix Pharmaceuticals Holding Corp

February 8, 2016May 19, 2016

Tonix to Discuss Fibromyalgia Study Results at BIO CEO & Investor Meet

News

Tonix Pharmaceuticals Holding Corp., a company developing next-generation therapeutics for fibromyalgia, episodic tension-type headaches, and post-traumatic stress disorder (PTSD), is among the participants at the 18th annual BIO CEO & Investor ... Read more

November 12, 2015November 12, 2015

Fibromyalgia Patients Show Sleep Improvements in Tonmya Study

News

Tonix Pharmaceuticals Holding Corp., a company dedicated to the invention and development of next-generation products for fibromyalgia, episodic tension-type headache, and post-traumatic stress disorder (PTSD), recently presented additional data from ... Read more

May 27, 2015May 27, 2015

Tonix Pharmaceuticals Announces Acceptance of Two Fibromyalgia-Related Abstracts for Presentation at EULAR

News

Tonix Pharmaceuticals Holding Corp, a clinical-stage firm currently advancing next-generation medicines to address the unmet needs related to post-traumatic stress disorder, fibromyalgia, and episodic tension-type headache, recently announced that two of the company’s abstracts were accepted and ... Read more

May 21, 2015May 21, 2015

Tonix Pharmaceuticals to Present Study Results of Experimental Fibromyalgia Therapy at EULAR

News

Tonix Pharmaceuticals Holding Corp., a clinical-stage company that develops first-in-class medicines for common disorders of the central nervous system, including post-traumatic stress disorder, fibromyalgia and episodic tension-type headache, recently announced the presentation ... Read more